## IQV: IQVIA Holdings, Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.96 indicates fundamental undervaluation. Quality metrics strong (ROE 19%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-2.3% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($210.13)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 5
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Deutsche Bank Adjusts Price Target on IQVIA Holdings to $250 From $235, Maintains Buy Rating**
- Source: marketscreener.com | 20251219T140833 | Bullish | Relevance: 100%
- Deutsche Bank has increased its price target for IQVIA Holdings (NYSE: IQV) to $250 from $235, while reiterating a Buy rating on the stock. This adjustment reflects the bank's continued positive outlook on the company's performance and future prospects. The news follows similar adjustments from other financial institutions, indicating growing analyst confidence in IQVIA.

**2. Addenda Capital Inc. Raises Stock Position in IQVIA Holdings Inc. $IQV**
- Source: MarketBeat | 20251219T081545 | Bullish | Relevance: 100%
- Addenda Capital Inc. significantly increased its stake in IQVIA Holdings Inc. during Q3, buying an additional 11,885 shares and bringing their total holdings to 61,117 shares valued at $11.61 million. This comes as institutional ownership of IQVIA reaches approximately 89.62%, and Wall Street analysts maintain a "Moderate Buy" consensus rating with an average price target of $243.59. IQVIA also reported strong Q3 earnings, surpassing revenue and EPS estimates, and provided positive FY2025 guidance.

**3. Assenagon Asset Management S.A. Acquires 30,798 Shares of IQVIA Holdings Inc. $IQV**
- Source: MarketBeat | 20251218T082212 | Bullish | Relevance: 100%
- Assenagon Asset Management S.A. increased its stake in IQVIA Holdings Inc. (NYSE:IQV) by 14.4% in the third quarter, acquiring an additional 30,798 shares. This purchase brings their total holdings to 245,099 shares, valued at approximately $46.55 million, representing about 0.14% of the company. Institutional investors now collectively own 89.62% of IQVIA, which holds a "Moderate Buy" consensus rating from analysts.

**4. Stifel raises IQVIA Holdings stock price target to $273 on recovery outlook**
- Source: Investing.com Canada | 20251217T200922 | Bullish | Relevance: 99%
- Stifel has increased its price target for IQVIA Holdings (NYSE:IQV) stock to $273.00 from $254.00, maintaining a Buy rating based on insights from recent investor meetings and the industry's recovery trajectory extending into 2026. The firm expressed confidence in IQVIA's market positioning as a "best-in-class player" and expects the company to return to medium-term revenue growth of 6%-9%. This adjusted target suggests significant upside from the current price, with the stock trading near its 52-week high.

**5. Stifel raises IQVIA Holdings stock price target to $273 on recovery outlook**
- Source: Investing.com UK | 20251217T193355 | Bullish | Relevance: 99%
- Stifel has increased its price target for IQVIA Holdings (NYSE:IQV) stock to $273.00 from $254.00, maintaining a Buy rating based on an anticipated industry recovery extending into 2026. This adjustment follows investor meetings yielding insights into the company's strong market positioning and expected medium-term revenue growth of 6%-9%. The company has also recently undertaken strategic initiatives, including an amended credit agreement and a collaboration with Amazon Web Services.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Morgan Stanley | $265 | $250 | +6% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($1.46M) |
| Sells | 1 ($5.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.4% (-0.9%)
- Blackrock Inc.: 8.7% (+4.5%)
- Harris Associates L.: 6.7% (-3.1%)
- State Street Corpora: 4.4% (-1.0%)
- JPMORGAN CHASE & CO: 3.9% (+110.0%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.3% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $5.8M in recent transactions.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.96 indicates undervaluation relative to growth. Analyst sentiment positive (1 raises, avg +6%). Insider selling cluster ($5.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.6B |
| Beta | 1.37 |
| 52W Range | $134.65 - $234.30 |
| Short Interest | 3.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.96 |
| Forward P/E | 17.1 |
| Current P/E | 18.6 |
| YoY Growth | 8.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 0.0% to -2.3% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.3pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.21x) but short-term weakness (below SMA20). MACD histogram bearish (-1.03), momentum weakening. RSI neutral at 49. Elevated volume (1.7x 20MA), institutional activity likely. OFD pattern: -MTH (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.27% (CS: 26) | Weak |
| RSI_14 | 48.6 | Neutral |
| MACD Histogram | -1.03 | Bearish |
| vs SMA20 | 0.981x | Below |
| vs SMA50 | 1.011x | Above |
| vs SMA200 | 1.211x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $220.71
- **Stop Loss:** $210.13 (4.8% risk)
- **Target:** $241.87 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 113
- **Position Value:** $24,940.23
- **Portfolio %:** 24.94%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-05 (Est: $3.40)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.98 | $3.00 | +0.8% |
| 2025Q2 | $2.77 | $2.81 | +1.4% |
| 2025Q1 | $2.63 | $2.70 | +2.6% |
| 2024Q4 | $3.11 | $3.12 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*